Editorial
doi: 10.1056/NEJM200206063462313.
When increased therapeutic benefit comes at increased cost
- PMID: 12050345
- DOI: 10.1056/NEJM200206063462313
Item in Clipboard
Editorial
When increased therapeutic benefit comes at increased cost
N Engl J Med.
.
No abstract available
Comment in
-
Aspirin, clopidogrel, or both for secondary prevention of coronary disease.N Engl J Med. 2003 Feb 6;348(6):560-3; author reply 560-3. N Engl J Med. 2003. PMID: 12572583 No abstract available.
-
Aspirin, clopidogrel, or both for secondary prevention of coronary disease.N Engl J Med. 2003 Feb 6;348(6):560-3; author reply 560-3. N Engl J Med. 2003. PMID: 12572584 No abstract available.
Comment on
-
Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.N Engl J Med. 2002 Jun 6;346(23):1800-6. doi: 10.1056/NEJM200206063462309. N Engl J Med. 2002. PMID: 12050341
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
